Literature DB >> 33029951

Cognitive and motor deficits in older adults with HIV infection: Comparison with normal ageing and Parkinson's disease.

Eva M Müller-Oehring1,2, Rosemary Fama1,2, Taylor F Levine3, Cheshire Hardcastle2, Ryan Goodcase1, Talora Martin3, Varsha Prabhakar3, Helen M Brontë-Stewart3,4, Kathleen L Poston3,4, Edith V Sullivan1, Tilman Schulte2,5.   

Abstract

Despite the life-extending success of antiretroviral pharmacotherapy in HIV infection (HIV), the prevalence of mild cognitive impairment in HIV remains high. Near-normal life expectancy invokes an emerging role for age-infection interaction and a potential synergy between immunosenescence and HIV-related health factors, increasing risk of cognitive and motor impairment associated with degradation in corticostriatal circuits. These neural systems are also compromised in Parkinson's disease (PD), which could help model the cognitive deficit pattern in HIV. This cross-sectional study examined three groups, age 45-79 years: 42 HIV, 41 PD, and 37 control (CTRL) participants, tested at Stanford University Medical School and SRI International. Neuropsychological tests assessed executive function (EF), information processing speed (IPS), episodic memory (MEM), visuospatial processing (VSP), and upper motor (MOT) speed and dexterity. The HIV and PD deficit profiles were similar for EF, MEM, and VSP. Although only the PD group was impaired on MOT compared with CTRL, MOT scores were related to cognitive scores in HIV but not PD. Performance was not related to depressive symptoms, socioeconomic status, or CD4+ T-cell counts. The overlap of HIV-PD cognitive deficits implicates frontostriatal disruption in both conditions. The motor-cognitive score relation in HIV provides further support for the hypothesis that these processes share similar underlying mechanisms in HIV infection possibly expressed with or exacerbated by ageing.
© 2020 British Psychological Society.

Entities:  

Keywords:  HIV infection; Parkinson’s disease; ageing; cognition; motor abilities

Year:  2020        PMID: 33029951      PMCID: PMC8026757          DOI: 10.1111/jnp.12227

Source DB:  PubMed          Journal:  J Neuropsychol        ISSN: 1748-6645            Impact factor:   2.864


  68 in total

1.  Parkinsonism: onset, progression, and mortality. 1967.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  2001-11       Impact factor: 9.910

2.  Combined effects of aging and HIV infection on semantic verbal fluency: a view of the cortical hypothesis through the lens of clustering and switching.

Authors:  Jennifer E Iudicello; Steven Paul Woods; Reena Deutsch; Igor Grant
Journal:  J Clin Exp Neuropsychol       Date:  2012-01-31       Impact factor: 2.475

3.  Effect of ageing on neurocognitive function by stage of HIV infection: evidence from the Multicenter AIDS Cohort Study.

Authors:  Karl Goodkin; Eric N Miller; Christopher Cox; Sandra Reynolds; James T Becker; Eileen Martin; Ola A Selnes; David G Ostrow; Ned C Sacktor
Journal:  Lancet HIV       Date:  2017-07-14       Impact factor: 12.767

4.  Selective Vulnerability of Striatal D2 versus D1 Dopamine Receptor-Expressing Medium Spiny Neurons in HIV-1 Tat Transgenic Male Mice.

Authors:  Christina J Schier; William D Marks; Jason J Paris; Aaron J Barbour; Virginia D McLane; William F Maragos; A Rory McQuiston; Pamela E Knapp; Kurt F Hauser
Journal:  J Neurosci       Date:  2017-05-04       Impact factor: 6.167

Review 5.  The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy.

Authors:  Ned Sacktor
Journal:  J Neurovirol       Date:  2002-12       Impact factor: 2.643

6.  Nadir CD4 cell count predicts neurocognitive impairment in HIV-infected patients.

Authors:  Jose A Muñoz-Moreno; Carmina R Fumaz; Maria J Ferrer; Anna Prats; Eugènia Negredo; Maite Garolera; Núria Pérez-Alvarez; José Moltó; Guadalupe Gómez; Bonaventura Clotet
Journal:  AIDS Res Hum Retroviruses       Date:  2008-10       Impact factor: 2.205

7.  Higher frequency of dementia in older HIV-1 individuals: the Hawaii Aging with HIV-1 Cohort.

Authors:  V Valcour; C Shikuma; B Shiramizu; M Watters; P Poff; O Selnes; P Holck; J Grove; N Sacktor
Journal:  Neurology       Date:  2004-09-14       Impact factor: 9.910

8.  Premature and accelerated aging: HIV or HAART?

Authors:  Reuben L Smith; Richard de Boer; Stanley Brul; Yelena Budovskaya; Hans van Spek
Journal:  Front Genet       Date:  2013-01-28       Impact factor: 4.599

Review 9.  HIV-1-associated neurocognitive disorder: epidemiology, pathogenesis, diagnosis, and treatment.

Authors:  Christian Eggers; Gabriele Arendt; Katrin Hahn; Ingo W Husstedt; Matthias Maschke; Eva Neuen-Jacob; Mark Obermann; Thorsten Rosenkranz; Eva Schielke; Elmar Straube
Journal:  J Neurol       Date:  2017-05-31       Impact factor: 4.849

10.  Parkinsonism in HIV infected patients during antiretroviral therapy - data from a Brazilian tertiary hospital.

Authors:  Luis Filipe Dehner; Mariana Spitz; João Santos Pereira
Journal:  Braz J Infect Dis       Date:  2016-07-20       Impact factor: 3.257

View more
  1 in total

Review 1.  Humanized Mice for Infectious and Neurodegenerative disorders.

Authors:  Prasanta K Dash; Santhi Gorantla; Larisa Poluektova; Mahmudul Hasan; Emiko Waight; Chen Zhang; Milica Markovic; Benson Edagwa; Jatin Machhi; Katherine E Olson; Xinglong Wang; R Lee Mosley; Bhavesh Kevadiya; Howard E Gendelman
Journal:  Retrovirology       Date:  2021-06-05       Impact factor: 3.768

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.